Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CYY292 |
Synonyms | |
Therapy Description |
CYY292 is an Fgfr1 inhibitor, which reduces downstream signaling and potentially decreases tumor cell growth and metastasis (PMID: 37588207). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
CYY292 | CYY-292|CYY 292 | FGFR1 Inhibitor 28 | CYY292 is an Fgfr1 inhibitor, which reduces downstream signaling and potentially decreases tumor cell growth and metastasis (PMID: 37588207). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
FGFR1 positive | glioblastoma | sensitive | CYY292 | Preclinical - Cell line xenograft | Actionable | In a preclinical study, CYY292 inhibited Fgfr1 downstream signaling, proliferation, migration, and invasion in Fgfr1-expressing glioblastoma cell lines in culture, inhibited tumor growth in a cell line xenograft model, and inhibited growth and improved survival in an orthotopic xenograft model of glioblastoma (PMID: 37588207). | 37588207 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|